Danielle Kamato Selected Research

galactosaminoglycan

1/2018

Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Danielle Kamato Research Topics

Disease

20	Atherosclerosis 04/2022 - 04/2013
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2014
4	Thrombosis (Thrombus) 01/2021 - 08/2018
4	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2019
4	Inflammation (Inflammations) 06/2020 - 01/2019
3	Vascular Diseases (Vascular Disease) 12/2019 - 02/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2017
2	Neoplasms (Cancer) 06/2020 - 04/2020
2	Immune System Diseases (Immune Disorders) 06/2020 - 01/2019
2	Insulin Resistance 12/2018 - 05/2017
1	Infections 02/2022
1	Hyperglycemia 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Myocardial Infarction 01/2021
1	Weight Gain 01/2021
1	Bacterial Infections (Bacterial Infection) 06/2020
1	Obesity 06/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Hypertrophy 01/2019
1	Metabolic Diseases (Metabolic Disease) 12/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2016

Drug/Important Bio-Agent (IBA)

11	Proteoglycans (Proteoglycan)IBA 01/2022 - 04/2013
10	GlycosaminoglycansIBA 01/2022 - 04/2013
9	LipidsIBA 01/2022 - 07/2013
5	Lipoproteins (Lipoprotein)IBA 11/2020 - 01/2016
5	Pharmaceutical PreparationsIBA 04/2020 - 04/2014
4	LDL Lipoproteins (beta Lipoproteins)IBA 06/2020 - 07/2013
4	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2019 - 07/2013
3	Thrombin FDA Link 01/2019 - 04/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022 - 06/2020
2	Biological ProductsIBA 12/2019 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	BiglycanIBA 01/2018 - 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2022
1	Endothelin-1 (Endothelin 1)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	CurcuminIBA 04/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2021
1	LigandsIBA 04/2021
1	dapagliflozinIBA 01/2021
1	empagliflozinIBA 01/2021
1	CanagliflozinIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	ferric oxide (iron oxide)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	artemisinin (artemisinine)IBA 11/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2020
1	canakinumab FDA Link 06/2020
1	LipopolysaccharidesIBA 06/2020
1	EndotoxinsIBA 06/2020
1	lysophosphatidic acidIBA 12/2019
1	Lysophosphatidic Acid ReceptorsIBA 12/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Histones (Histone)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 12/2018
1	FibrinIBA 08/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2018
1	Peptides (Polypeptides)IBA 08/2018
1	galactosaminoglycanIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Plasminogen Activator Inhibitor 1IBA 01/2018
1	Insulin (Novolin)FDA Link 05/2017
1	EnzymesIBA 01/2016
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 02/2015
1	IsomerasesIBA 02/2015
1	gingerolIBA 07/2013
1	S 6 (S-6)IBA 07/2013
1	Tyrosine (L-Tyrosine)FDA Link 04/2013
1	Endothelins (Endothelin)IBA 04/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2013

Therapy/Procedure

5	Therapeutics 06/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2021
1	Precision Medicine 07/2019